📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
27
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
47%
🔄 Reverse Split
55%
• 50-day avg $0.31 below $1 exchange minimum
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($6000M, 12115% of market cap)
• Active ATM program with $8M remaining capacity
💹 Market Data
Market Cap$49.53M
Shares Outstanding194.68M
Float143.95M
Cash$2.47M
Debt$27.63M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 30.7% shares (2025Q4 vs prior)
14 institutional holders · 443.8K shares
#1
Virtu Financial LLC
175.1K shares
#2
TWO SIGMA SECURITIES, LLC
53.1K shares
#3
XTX Topco Ltd
46.0K shares
+ 11 more holders Sign up free to view →
📉 Short Interest
Short Interest6.85M
Days to Cover3.1
% of Float4.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
F-3/A
SHELF
May 04, 2026
6-K
8K EVENT
May 04, 2026
F-3
SHELF
May 01, 2026
6-K
8K EVENT
Apr 22, 2026
424B5
ATM
Apr 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GNS
📊 GNS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GNS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.